HKD 3.87
(0.78%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 305.46 Million CNY | 7.02% |
2022 | 285.42 Million CNY | 40.92% |
2021 | 202.54 Million CNY | 2.7% |
2020 | 197.22 Million CNY | 37.17% |
2019 | 143.77 Million CNY | 38.76% |
2018 | 103.61 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 113.27 Million CNY | 0.0% |
2024 Q1 | 113.27 Million CNY | 34.22% |
2023 Q3 | 77.9 Million CNY | 14.01% |
2023 FY | 305.46 Million CNY | 7.02% |
2023 Q4 | 84.39 Million CNY | 8.33% |
2023 Q2 | 68.33 Million CNY | 0.0% |
2023 Q1 | 68.33 Million CNY | -1.46% |
2022 Q3 | 69.35 Million CNY | 2.83% |
2022 Q2 | 67.44 Million CNY | 0.0% |
2022 Q1 | 67.44 Million CNY | 61.19% |
2022 FY | 285.42 Million CNY | 40.92% |
2022 Q4 | 69.35 Million CNY | 0.0% |
2021 Q2 | 58.2 Million CNY | 0.0% |
2021 Q1 | 58.2 Million CNY | 4.91% |
2021 Q4 | 41.84 Million CNY | 0.0% |
2021 Q3 | 41.84 Million CNY | -28.12% |
2021 FY | 202.54 Million CNY | 2.7% |
2020 Q1 | 41.84 Million CNY | 0.0% |
2020 Q4 | 55.48 Million CNY | 0.0% |
2020 Q3 | 55.48 Million CNY | 32.59% |
2020 Q2 | 41.84 Million CNY | 0.0% |
2020 FY | 197.22 Million CNY | 37.17% |
2019 FY | 143.77 Million CNY | 38.76% |
2018 FY | 103.61 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 14.89 Million HKD | -1951.051% |
Lee & Man Chemical Company Limited | 473.28 Million HKD | 35.459% |